173 related articles for article (PubMed ID: 16438872)
1. [Prognostic factor of primary liver cancer treated by hypofractionated three-dimensional conformal radiotherapy].
Liang SX; Jiang GL; Zhu XD; Fu XL; Li FX; Huang QF; Wang AY; Chen L; Lu HJ
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):613-5. PubMed ID: 16438872
[TBL] [Abstract][Full Text] [Related]
2. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer].
Sun HW; Chen LH; Wei CJ; Zheng XK; Li QS; Guan J
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1133-6. PubMed ID: 19726341
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma.
Liang SX; Zhu XD; Lu HJ; Pan CY; Li FX; Huang QF; Wang AY; Chen L; Fu XL; Jiang GL
Cancer; 2005 May; 103(10):2181-8. PubMed ID: 15812834
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
5. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
6. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
[TBL] [Abstract][Full Text] [Related]
7. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.
Lin CS; Jen YM; Chiu SY; Hwang JM; Chao HL; Lin HY; Shum WY
Jpn J Clin Oncol; 2006 Apr; 36(4):212-7. PubMed ID: 16613896
[TBL] [Abstract][Full Text] [Related]
8. Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy.
Hamamoto Y; Niino K; Ishiyama H; Hosoya T
Radiat Med; 2004; 22(5):316-23. PubMed ID: 15553012
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
11. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
Hsu WC; Chan SC; Ting LL; Chung NN; Wang PM; Ying KS; Shin JS; Chao CJ; Lin GD
Jpn J Clin Oncol; 2006 Feb; 36(2):93-9. PubMed ID: 16517834
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis.
Rim CH; Yang DS; Park YJ; Yoon WS; Lee JA; Kim CY
Jpn J Clin Oncol; 2012 Aug; 42(8):721-9. PubMed ID: 22689916
[TBL] [Abstract][Full Text] [Related]
13. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
[TBL] [Abstract][Full Text] [Related]
14. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.
Xu ZY; Liang SX; Zhu J; Zhu XD; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):189-95. PubMed ID: 16542787
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial.
Mornex F; Girard N; Beziat C; Kubas A; Khodri M; Trepo C; Merle P
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1152-8. PubMed ID: 17145534
[TBL] [Abstract][Full Text] [Related]
16. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control.
Sze WM; Lee AW; Yau TK; Yeung RM; Lau KY; Leung SK; Hung AW; Lee MC; Chappell R; Chan K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):21-7. PubMed ID: 15093895
[TBL] [Abstract][Full Text] [Related]
17. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma.
Toya R; Murakami R; Baba Y; Nishimura R; Morishita S; Ikeda O; Kawanaka K; Beppu T; Sugiyama S; Sakamoto T; Yamashita Y; Oya N
Radiother Oncol; 2007 Sep; 84(3):266-71. PubMed ID: 17716760
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable.
Kim TH; Kim DY; Park JW; Kim YI; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
Am J Clin Oncol; 2006 Dec; 29(6):568-75. PubMed ID: 17148993
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization.
Zhang XB; Wang JH; Yan ZP; Qian S; Du SS; Zeng ZC
Cancer; 2009 Mar; 115(6):1245-52. PubMed ID: 19156918
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
